t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemia

被引:27
|
作者
Vizmanos, JL
Larráyoz, MJ
Lahortiga, I
Floristán, F
Alvarez, C
Odero, MD
Novo, FJ
Calasanz, MJ
机构
[1] Univ Navarra, Dept Genet, Sch Sci, E-31080 Pamplona, Spain
[2] Hosp Cruces, Hematol Serv, Serv Vasco Salud Osakidetza, Barcelona, Spain
来源
GENES CHROMOSOMES & CANCER | 2003年 / 36卷 / 04期
关键词
D O I
10.1002/gcc.10174
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recently, it was shown that t(10;16)(q22;p13) fuses the MORF and CREBBP genes in a case of childhood acute myeloid leukemia (AML) M5a, with a complex karyotype containing other rearrangements. Here, we report a new case with the MORF-CREBBP fusion in an 84-year-old patient diagnosed with AML M5b, in which the t(I 0; 1 6)(q22;p 13) was the only cytogenetic aberration. This supports that this is a recurrent pathogenic translocation in AML. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:402 / 405
页数:4
相关论文
共 50 条
  • [41] Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia
    Pullarkat S.T.
    Pullarkat V.
    Kroft S.H.
    Wilson C.S.
    Ahsanuddin A.N.
    Mann K.P.
    Thein M.
    Grody W.W.
    Brynes R.K.
    Journal of Hematopathology, 2009, 2 (1) : 27 - 33
  • [42] Duplication of der(21) t(8;21)(q22;q22) in Acute Myeloid Leukemia
    Yamamoto, Katsuya
    Okamura, Atsuo
    Matsuoka, Hiroshi
    Minami, Hironobu
    INTERNAL MEDICINE, 2014, 53 (01) : 73 - 74
  • [43] Translocation t(8;21)(q22;q22) and its variants in acute myeloid leukemia
    Jovanovi, J.
    Evi, Vesna Or
    Deni-Fekete, M.
    Bii, S.
    Goti, M.
    Bokovi, D.
    CHROMOSOME RESEARCH, 2005, 13 : 190 - 190
  • [44] Systemic mastocytosis with an associated t(8;21)(q22;q22) acute myeloid leukemia
    Wimmer, Jordan
    Hurstel, Remy
    BLOOD, 2021, 137 (18) : 2564 - 2564
  • [45] Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22)
    Seftel, MD
    Bruyere, H
    Copland, M
    Hogge, DE
    Horsman, DE
    Nantel, SH
    Shepherd, JD
    Lavoie, JC
    Le, A
    Sutherland, HJ
    Toze, CL
    Nevill, TJ
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 69 (04) : 193 - 199
  • [46] Fusion of the OTT and MAL genes in infant acute magakaryoblastic leukemia with t(1;22)(p13;q13).
    Taki, T
    Akano, Y
    Taniwaki, M
    Chen, YZ
    Soeda, E
    Fukushima, T
    Tsuchida, M
    Hayashi, Y
    BLOOD, 2001, 98 (11) : 156B - 156B
  • [47] Prognosis and treatment outcome in patients with acute myeloid Leukemia with t(8;21)(q22;q22)
    Chih-Cheng Chen
    Jyh-Pyng Gau
    Yuan-Bin Yu
    Chang-Hsien Lu
    Kuan-Der Lee
    Jie-Yu You
    Advances in Therapy, 2007, 24 : 907 - 920
  • [48] Prognosis and treatment outcome in patients with acute myeloid leukemia with t(8;21)(q22;q22)
    Chen, Chih-Cheng
    Gau, Jyh-Pyng
    Yu, Yuan-Bin
    Lu, Chang-Hsien
    Lee, Kuan-Der
    You, Jie-Yu
    ADVANCES IN THERAPY, 2007, 24 (04) : 907 - 920
  • [49] ACUTE MYELOID LEUKEMIA WITH T(16;21) (P11;Q22): DESCRIPTION OF ACASE AND REVISION OF LITERATURE
    Atance Pasarisas, M.
    Blas, C.
    Soto, C.
    Lopez-Lorenzo, J. L.
    Villaescusa, M. T.
    Salido, M.
    Serrano, C.
    Mata, R.
    LLamas-Sillero, P.
    Salgado Rocio, N.
    HAEMATOLOGICA, 2015, 100 : 260 - 261
  • [50] Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22)
    Zhang, Lixia
    Li, Qinghua
    Li, Wei
    Liu, Bingcheng
    Wang, Ying
    Lin, Dong
    Zhou, Chunlin
    Li, Chengwen
    Wang, Jianxiang
    Mi, Yingchang
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (06) : 786 - 792